Lack of Evidence of Sexual Transmission of Hepatitis C Virus in a Prospective Cohort Study of Men Who Have Sex With Men
Michel Alary, MD, PhD,
Jean R. Joly, MD, FRCPC, MSPH, MBA,
Jean Vincelette, MD, MSc, FRCPC,
René Lavoie, BA,
Bruno Turmel, MD and
Robert S. Remis, MD, MPH, FRCPC
Michel Alary is with the Unité de recherche en santé des populations, Centre hospitalier affilié universitaire de Québec and Université Laval, Québec City, Québec. Michel Alary and Bruno Turmel are with the Institut national de santé publique du Québec, Québec and Mon-tréal, Québec. Jean R. Joly is with the Laboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec. Jean Vincelette is with the Service de microbiologie, Centre hospitalier de lUniversité de Montréal, Hôpital St-Luc, Montréal, Québec. René Lavoie is with Action Séro-Zéro, Montréal. Robert S. Remis is with the Department of Public Health Sciences, University of Toronto, Toronto, Ontario.
Correspondence: Requests for reprints should be sent to Jean R. Joly, MD, FRCPC, MSPH, MBA, Laboratoire de santé publique du Québec, 20045 chemin Sainte-Marie, Sainte-Anne-de-Bellevue, Québec H9X 3R5 Canada (e-mail: jean.joly{at}inspq.qc.ca).
Objectives. We studied the prevalence and incidence of hepatitisC virus (HCV) infection in the ongoing Omega Cohort Study ofmen who have sex with men (MSM).
Methods. From January to September 2001, consenting men (n =1085) attending a follow-up visit to the ongoing Omega CohortStudy were tested for HCV. If the test results were positivefor HCV, we compared them with test results from previous serumsamples collected from the time of entry into the original cohortstudy to determine the time of infection.
Results. HCV prevalence at entry was 2.9% and was strongly associatedwith injection drug use (32.9% vs 0.3%, P<.0001). Only 1seroconversion was identified in 2653 person-years of follow-up(incidence rate = 0.038 per 100 person-years). The seroconverterwas an active injection drug user who reported needle sharing.
Conclusions. Sexual transmission of HCV among MSM appears tobe rare.
This article has been cited by other articles:
F. Jin, G. P. Prestage, G. Matthews, I. Zablotska, P. Rawstorne, S. C. Kippax, J. M. Kaldor, and A. E. Grulich Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia
Sex Transm Inf,
February 1, 2010;
86(1):
25 - 28.
[Abstract][Full Text][PDF]
J. R. Lama, A. Lucchetti, C. Cabezas, L. Suarez-Ognio, and Jorge Sanchez for the Peruvian HIV Sentinel Survei Lack of Evidence of Hepatitis C and HIV Co-Infection among Men Who Have Sex with Men in Peru
Am J Trop Med Hyg,
July 1, 2009;
81(1):
184 - 186.
[Abstract][Full Text][PDF]
M. Russell, M.-J. Chen, T. H. Nochajski, M. Testa, S. J. Zimmerman, and P. S. Hughes Risky Sexual Behavior, Bleeding Caused by Intimate Partner Violence, and Hepatitis C Virus Infection in Patients of a Sexually Transmitted Disease Clinic
Am J Public Health,
April 1, 2009;
99(S1):
S173 - S179.
[Abstract][Full Text][PDF]
E. Hamlyn, A. Peer, and P. Easterbrook Sexual health and HIV in travellers and expatriates
Occup. Med.,
August 1, 2007;
57(5):
313 - 321.
[Abstract][Full Text][PDF]
C. Poulin MSc, M. Alary MD PhD, G. Lambert MD, G. Godin PhD, S. Landry MA, H. Gagnon MA, E. Demers MSc, E. Morarescu MD MSc, J. Rochefort MSc, and C. Claessens MSc Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons
Can. Med. Assoc. J.,
July 31, 2007;
177(3):
252 - 256.
[Abstract][Full Text][PDF]
J. L. Dienstag Hepatitis C: A Bitter Harvest
Ann Intern Med,
May 16, 2006;
144(10):
770 - 771.
[Full Text][PDF]
T. Wong and S. S. Lee Hepatitis C: a review for primary care physicians
Can. Med. Assoc. J.,
February 28, 2006;
174(5):
649 - 659.
[Abstract][Full Text][PDF]